← Back to Search

Behavioral Intervention

Intervention/Treatment for Obesity (OVERCOME-IT Trial)

N/A
Waitlist Available
Led By Amber W Kinsey, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 4
Awards & highlights

OVERCOME-IT Trial Summary

This trial aims to gather initial information on whether a new resistance training program, which is conducted remotely, is practical, well-received, and has positive effects.

Who is the study for?
This trial is for Black or African American women aged 30-64 who are not regularly doing resistance training and have conditions like overweight, obesity, prediabetes, diabetes, or hypertension. Participants must live near the University, be willing to exercise at home using an internet-connected device and get medical clearance if needed.Check my eligibility
What is being tested?
The study tests a new remotely delivered resistance training program designed for cardiometabolic health improvement. It aims to see how feasible and effective this home-based workout regimen can be for participants.See study design
What are the potential side effects?
Since the intervention involves physical exercise, potential side effects may include muscle soreness, fatigue, joint pain or injury. However, these are common with any new exercise routine and typically decrease over time as the body adapts.

OVERCOME-IT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of recruitment
Feasibility of retention
Intervention adherence
Secondary outcome measures
Change in HbA1C
Change in blood pressure
Change in body composition
+3 more

Side effects data

From 2010 Phase 2 trial • 167 Patients • NCT00112151
66%
Other noncardiovascular serious adverse events
13%
Other nonserious adverse events
11%
Persistently elevated PSA
4%
Total serious cardiovascular adverse events
4%
Persistently elevated HCT >= 54%
2%
Elevated AUA
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Lower-range T
Higher-range T

OVERCOME-IT Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention/TreatmentExperimental Treatment1 Intervention
A home-based resistance training condition that is delivered through a web-based platform.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistance Training
2019
Completed Phase 2
~1190

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,590 Previous Clinical Trials
2,281,426 Total Patients Enrolled
73 Trials studying Obesity
474,278 Patients Enrolled for Obesity
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,216,323 Total Patients Enrolled
41 Trials studying Obesity
254,780 Patients Enrolled for Obesity
Amber W Kinsey, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research include individuals aged 55 and above?

"This research is seeking individuals aged 30 years and older but less than 64 years."

Answered by AI

What are the specific criteria for individuals to qualify as participants in this research project?

"Enrollment in this study requires individuals with obesity aged between 30 and 64. The trial aims to recruit a total of 36 participants."

Answered by AI

Are there any available openings for patients to participate in this medical study?

"The data on clinicaltrials.gov indicates that this particular study is not actively seeking participants. Originally uploaded on September 1, 2024 and most recently updated on April 10, 2024. While recruitment for this trial is currently closed, there are a total of 1116 other trials open for enrollment at present."

Answered by AI
~24 spots leftby Jun 2026